Endocannabinoid System FAQ
What are the benefits of activating the endocannabinoid system?
The activation of the endocannabinoid system has been linked to a variety of potential health benefits. The main role of the endocannabinoid system is to regulate vital physiological functions—sleep, appetite, pain, and immunological response—and maintain homeostasis. Endocannabinoid receptors, endocannabinoids, and the enzymes that break them down help activate the ECS and keep our bodies in balance. Activating the ECS has been associated with improved sleep, chronic pain reduction, and overall improved quality of life.
How do you know if you have an endocannabinoid deficiency?
Although there is no conclusive test for endocannabinoid deficiency, the condition is often accompanied by poor digestion, low energy, disrupted sleep, a bad mood, chronic pain, and other symptoms. If you experience persistent symptoms, seek medical advice from a healthcare expert who is familiar with the endocannabinoid system.
How can I get endocannabinoids naturally?
You can enhance your endocannabinoid levels by engaging in activities that increase endocannabinoid signaling, such as exercise, meditation, or eating a well-balanced diet rich in fatty acids like omega-3. If you live on the Mediterranean, you’re in luck, because the Mediterranean diet is high in all the good stuff that naturally boosts endocannabinoids: sardines, anchovies, hemp seed and hemp oil, olive oil, and walnuts.
For the rest of us mortals who don’t follow the Mediterranean diet, here are some more foods and activities that support healthy endocannabinoids:
Flaxseed and flax oil
Phytocannabinoids from medical cannabis—like CBD, THC, and Delta 8 THC—may also boost endocannabinoid synthesis. Delta 8 THC is another cannabinoid found in the cannabis plant. Read more about Delta 8 and all its benefits right here.
Do all plants have endocannabinoids?
Not all plants produce endocannabinoids. Cannabinoids are unique compounds that are primarily found in the cannabis plant, but they can also be found in other plants such as:
What organ produces endocannabinoids?
Endocannabinoids are produced on-demand by cells located in various tissues and organs, such as:
Endocannabinoid receptors CB1 and CB2 are found throughout the bodies of all animals and humans, particularly in the central and peripheral neurological systems, the immune system, and the digestive tract. The prevalence of these receptors shows that the endocannabinoid system regulates many body activities, including pain perception, mood, hunger, and immunological response.
Is THC part of the endocannabinoid system?
THC is not a component of the endocannabinoid system, but it can activate its endocannabinoid receptors (CB1 and CB2). THC is a phytocannabinoid present in cannabis plants.
How do THC and CBD impact weight loss?
THC and CBD might have contradictory effects on weight loss.
THC has been shown to increase food consumption and boost appetite, which can contribute to weight gain. These are the so-called munchies that are typically associated with medical marijuana. Strangely, THC can also trigger a decrease in overall body weight due to the control of endocannabinoid precursors and increased energy expenditure.
CBD, on the other hand, has been proven to have potential weight loss advantages by suppressing appetite and promoting fat breakdown in the body. Study results “suggest that cannabidiol has an anorexigenic effect, correlated with a decrease in body weight.”
Has the FDA approved cannabis?
The FDA has not approved cannabis for any medical use. However, the FDA has approved several drugs that contain individual cannabinoids.
Epidiolex is a CBD-based medicine used to treat seizures caused by Lennox-Gastaut syndrome and Dravet syndrome, two rare forms of epilepsy. (Abu-Sawwa, et. al.)
Marinol (dronabinol) is a synthetic cannabinoid, a version of THC, used to treat chemotherapy-induced nausea and vomiting. It also promotes appetite in patients suffering from AIDS-related wasting syndrome. (O’Donnell, et. al.)
Syndros, also called “liquid dronabinol,” is a synthetic cannabinoid used for the same purposes as marinol: to help people in chemotherapy with nausea and vomiting.
All of these cannabis-based medications have undergone comprehensive clinical trials and have been shown to be safe and effective. Patients should use these medications under the supervision and medical advice of a healthcare professional, as they may interact with other medications.
Is Delta 9 THC legal?
Delta 9 is legal on a federal level in the US. Under the 2018 Farm Bill, Delta 9 must be derived from hemp, and the THC content cannot exceed 0.3% by dry weight.
However, the legality of hemp-derived products is determined by each state individually. For example, our Delta 8 products are federally legal, but a number of US states still ban Delta 8 outright.
All our Delta 9 THC edibles are legal in compliance with the Farm Bill. To make sure they are legal in your state, read up on our state-by-state guide to Delta 9 legality.
Lerner, R., Lutz, B., & Bindila, L. (2013, September 19). Tricks and Tracks in the Identification and Quantification of Endocannabinoids. ELS. https://doi.org/10.1002/9780470015902.a0023407
van den Hoogen, N. J., Harding, E. K., D. Davidson, C. E., & Trang, T. (2021, December 17). Cannabinoids in Chronic Pain: Therapeutic Potential Through Microglia Modulation. Frontiers. https://doi.org/10.3389/fncir.2021.816747
Endocannabinoids in the regulation of appetite and body weight - PubMed. (2005, September 1). PubMed. https://doi.org/10.1097/00008877-200509000-00004
Endocannabinoids and sleep - PubMed. (2016, December 1). PubMed. https://doi.org/10.1016/j.neubiorev.2016.10.005
Marzo, V. D., Stella, N., & Zimmer, A. (n.d.). Endocannabinoid signalling and the deteriorating brain. PubMed Central (PMC). https://doi.org/10.1038/nrn3876
Pandey, R., Mousawy, K., Nagarkatti, M., & Nagarkatti, P. (2009, April 7). Endocannabinoids and immune regulation. PubMed Central (PMC). https://doi.org/10.1016/j.phrs.2009.03.019
Covey, D., Mateo, Y., Sulzer, D., Cheer, J. F., & Lovinger, D. M. (2017, April 25). Endocannabinoid modulation of dopamine neurotransmission. PubMed Central (PMC). https://doi.org/10.1016/j.neuropharm.2017.04.033
CB1 cannabinoid receptors are involved in neuroprotection via NF-kappa B inhibition - PubMed. (2005, April 1). PubMed. https://doi.org/10.1038/sj.jcbfm.9600047
Pagano C, Savarese B, Coppola L, Navarra G, Avilia G, Laezza C, Bifulco M. Cannabinoids in the Modulation of Oxidative Signaling. International Journal of Molecular Sciences. 2023; 24(3):2513. https://doi.org/10.3390/ijms24032513
Ashton, J. C., & Glass, M. (n.d.). The Cannabinoid CB2 Receptor as a Target for Inflammation-Dependent Neurodegeneration. PubMed Central (PMC). https://doi.org/10.2174/157015907780866884
Turcotte, C., Blanchet, M. R., Laviolette, M., & Flamand, N. (2016, July 11). The CB2 receptor and its role as a regulator of inflammation. PubMed Central (PMC). https://doi.org/10.1007/s00018-016-2300-4
Basu, S., & Dittel, B. N. (n.d.). Unraveling the Complexities of Cannabinoid Receptor 2 (CB2) Immune Regulation in Health and Disease. PubMed Central (PMC). https://doi.org/10.1007/s12026-011-8210-5
Cabral, G. A., & Griffin-Thomas, L. (2009, January 20). Emerging Role of the CB2 Cannabinoid Receptor in Immune Regulation and Therapeutic Prospects. PubMed Central (PMC). https://doi.org/10.1017/S1462399409000957
Basavarajappa, B. S. (n.d.). Critical Enzymes Involved in Endocannabinoid Metabolism. PubMed Central (PMC). https://doi.org/10.2174/092986607780090829
The endocannabinoid system and the brain - PubMed. (2013, January 1). PubMed. https://doi.org/10.1146/annurev-psych-113011-143739
Zou, S., & Kumar, U. (2018, March 13). Cannabinoid Receptors and the Endocannabinoid System: Signaling and Function in the Central Nervous System. PubMed Central (PMC). https://doi.org/10.3390/ijms19030833
Castillo, P. E., Younts, T. J., Chávez, A. E., & Hashimotodani, Y. (n.d.). Endocannabinoid signaling and synaptic function. PubMed Central (PMC). https://doi.org/10.1016/j.neuron.2012.09.020
The endocannabinoid system in mental disorders: Evidence from human brain studies. (2018, July 17). The Endocannabinoid System in Mental Disorders: Evidence From Human Brain Studies - ScienceDirect. https://doi.org/10.1016/j.bcp.2018.07.009
Elevated endogenous cannabinoids in schizophrenia - PubMed. (1999, June 3). PubMed. https://doi.org/10.1097/00001756-199906030-00008
Russo, E. B. (2016, July 1). Clinical Endocannabinoid Deficiency Reconsidered: Current Research Supports the Theory in Migraine, Fibromyalgia, Irritable Bowel, and Other Treatment-Resistant Syndromes. PubMed Central (PMC). https://doi.org/10.1089/can.2016.0009
Bristot, V., Poletto, G., Russiano Pereira, D. M., Hauck, M., Ceola Schneider, I. J., & Aguiar, A. S. (2022, May 18). The effects of exercise on circulating endocannabinoid levels—a protocol for a systematic review and meta-analysis - Systematic Reviews. BioMed Central. https://doi.org/10.1186/s13643-022-01980-x
Lutz, B., Marsicano, G., Maldonado, R., & Hillard, C. J. (n.d.). The endocannabinoid system in guarding against fear, anxiety and stress. PubMed Central (PMC). https://doi.org/10.1038/nrn4036
Clinical endocannabinoid deficiency (CECD): can this concept explain therapeutic benefits of cannabis in migraine, fibromyalgia, irritable bowel syndrome and other treatment-resistant conditions? - PubMed. (2004, April 1). PubMed. https://pubmed.ncbi.nlm.nih.gov/15159679/
The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: delta9-tetrahydrocannabinol, cannabidiol and delta9-tetrahydrocannabivarin - PubMed. (2008, January 1). PubMed. https://doi.org/10.1038/sj.bjp.0707442
Cannabinoids and appetite: food craving and food pleasure - PubMed. (2009, April 1). PubMed. https://doi.org/10.1080/09540260902782810
Mohammed, A., Alghetaa, H., Sultan, M., Singh, N. P., Nagarkatti, P., & Nagarkatti, M. (2020, June 16). Administration of Δ9‐Tetrahydrocannabinol (THC) Post‐Staphylococcal Enterotoxin B Exposure Protects Mice From Acute Respiratory Distress Syndrome and Toxicity. PubMed Central (PMC). https://doi.org/10.3389/fphar.2020.00893
Delta9-tetrahydrocannabinol inhibits cell cycle progression in human breast cancer cells through Cdc2 regulation - PubMed. (2006, July 1). PubMed. https://doi.org/10.1158/0008-5472.CAN-05-4566
Bie, B., Wu, J., Foss, J. F., & Naguib, M. (n.d.). An overview of the cannabinoid type 2 (CB2) receptor system and its therapeutic potential. PubMed Central (PMC). https://doi.org/10.1097/ACO.0000000000000616
Leweke, F. M., Piomelli, D., Pahlisch, F., Muhl, D., Gerth, C. W., Hoyer, C., Klosterkötter, J., Hellmich, M., & Koethe, D. (2012, March 20). Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia. PubMed Central (PMC). https://doi.org/10.1038/tp.2012.15
Anand, U., Jones, B., Korchev, Y., Bloom, S. R., Pacchetti, B., Anand, P., & Sodergren, M. H. (2020, September 11). CBD Effects on TRPV1 Signaling Pathways in Cultured DRG Neurons. PubMed Central (PMC). https://doi.org/10.2147/JPR.S258433
Patricio, F., Dávila, E. M., Patricio-Martínez, A., Del Carmen, N. A., Martínez, I., Aguilera, J., Perez-Aguilar, J. M., & Limón, I. D. (2022, September 2). Intrapallidal injection of cannabidiol or a selective GPR55 antagonist decreases motor asymmetry and improves fine motor skills in hemiparkinsonian rats. PubMed Central (PMC). https://doi.org/10.3389/fphar.2022.945836
Vučković, S., Srebro, D., Vujović, K. S., Vučetić, E., & Prostran, M. (2018, October 15). Cannabinoids and Pain: New Insights From Old Molecules. Frontiers. https://doi.org/10.3389/fphar.2018.01259
Russo, E. B. (n.d.). Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects. PubMed Central (PMC). https://doi.org/10.1111/j.1476-5381.2011.01238.x
Giacomo, S. D., Mariano, A., Gullì, M., Fraschetti, C., Vitalone, A., Filippi, A., Mannina, L., d’Abusco, A. S., & Sotto, A. D. (2021, November 5). Role of Caryophyllane Sesquiterpenes in the Entourage Effect of Felina 32 Hemp Inflorescence Phytocomplex in Triple Negative MDA-MB-468 Breast Cancer Cells. PubMed Central (PMC). https://doi.org/10.3390/molecules26216688
Pamplona, F. A., da Silva, L. R., & Coan, A. C. (2018, September 12). Potential Clinical Benefits of CBD-Rich Cannabis Extracts Over Purified CBD in Treatment-Resistant Epilepsy: Observational Data Meta-analysis. PubMed Central (PMC). https://doi.org/10.3389/fneur.2018.00759
King, K. M., Myers, A. M., Soroka‐Monzo, A. J., Tuma, R. F., Tallarida, R. J., Walker, E. A., & Ward, S. J. (2017, July 27). Single and combined effects of Δ9‐tetrahydrocannabinol and cannabidiol in a mouse model of chemotherapy‐induced neuropathic pain. PubMed Central (PMC). https://doi.org/10.1111/bph.13887
Ruver-Martins, A. C., Bicca, M. A., de Araujo, F. S., Lameiro de Noronha Sales Maia, B. H., Pamplona, F. A., da Silva, E. G., & Nascimento, F. P. (2022, July 12). Cannabinoid extract in microdoses ameliorates mnemonic and nonmnemonic Alzheimer’s disease symptoms: a case report - Journal of Medical Case Reports. BioMed Central. https://doi.org/10.1186/s13256-022-03457-w
Stoner SA. Effects of Marijuana on Mental Health: Anxiety Disorders. Alcohol & Drug Abuse Institute, University of Washington, June 2017. URL: http://adai.uw.edu/pubs/pdf/2017mjanxiety.pdf
Haddad, F., Dokmak, G., & Karaman, R. (2022, May 5). The Efficacy of Cannabis on Multiple Sclerosis-Related Symptoms. PubMed Central (PMC). https://doi.org/10.3390/life12050682
Cannabinoids and Prostate Cancer: A Systematic Review of Animal Studies - PubMed. (2020, August 29). PubMed. https://doi.org/10.3390/ijms21176265
Brugnatelli, V., Turco, F., Freo, U., & Zanette, G. (2020, April 21). Irritable Bowel Syndrome: Manipulating the Endocannabinoid System as First-Line Treatment. PubMed Central (PMC). https://doi.org/10.3389/fnins.2020.00371
Fearby, N., Penman, S., & Thanos, P. (2022, March 8). Effects of Δ9-Tetrahydrocannibinol (THC) on Obesity at Different Stages of Life: A Literature Review. PubMed Central (PMC). https://doi.org/10.3390/ijerph19063174
Pinto, J. S., & Martel, F. (2022, October 1). Effects of Cannabidiol on Appetite and Body Weight: A Systematic Review. PubMed Central (PMC). https://doi.org/10.1007/s40261-022-01205-y
Abu-Sawwa, R., & Stehling, C. (2019, October 19). Epidiolex (Cannabidiol) Primer: Frequently Asked Questions for Patients and Caregivers. PubMed Central (PMC). https://doi.org/10.5863/1551-6776-25.1.75
O’Donnell, B., Meissner, H., & Gupta, V. (2022, September 5). Dronabinol - StatPearls - NCBI Bookshelf. Dronabinol - StatPearls - NCBI Bookshelf. https://www.ncbi.nlm.nih.gov/books/NBK557531/